With the rapid growth of outpatient surgery and ambulatory surgical centers, wound hemostasis has become a critical factor in clinic operational efficiency and patient safety. For medical device distributors, the 2026 market for advanced absorbable hemostats is shifting from "basic functionality" toward "precision, safety, and complete absorbability."
Based on the latest clinical evidence and materials engineering advances, this article distills 4 key technical indicators to help distributors scientifically evaluate products and accurately match their downstream clinic clients with either "high cost-performance" or "premium" product lines.
1. Absorption Rate: The "First Principle" of Hemostatic Efficiency
Clinical significance: The absorption rate of a hemostatic material directly determines intraoperative waiting time, risk of re-bleeding, and postoperative drainage duration.
Real-world data support:
According to a minipig liver hemorrhage model study published in the Chinese Journal of Tissue Engineering Research , oxidized regenerated cellulose (ORC) hemostatic material achieves complete hemostasis within 3 minutes. The study demonstrated that ORC's intraoperative hemostatic time showed no statistically significant difference from leading imported products (P > 0.05)
| Material Type | Time to Hemostasis | Absorption Time | Key Characteristics |
|---|---|---|---|
| ORC (e.g., Surgiclean® Absorbable Gauze) | ≤3 minutes | ≤28 days | Woven structure, maintains integrity when wet |
| Plant Starch Particles (e.g., Surgiclean® MPH) | ≤1–3 minutes | 14 days | 100% plant-derived, thrombin-free |
| Gelatin Sponge | 2–5 minutes | 4–8 weeks | Fragile when wet, requires dry gauze compression |
| Collagen | 2–4 minutes | 3–8 weeks | Flexible but softens upon blood contact |
Ultrasound examination in the same study revealed that ORC materials gradually degraded with extended implantation time, with most degraded and absorbed by 56 days post-modeling .
Selection advice for distributors:
For outpatient minor surgeries (biopsy, mole removal, hernioplasty): Prioritize ORC or starch-based products – fast absorption, minimal foreign body reaction.
For orthopedic or deep-tissue surgeries: Retain some gelatin-based products for bone surfaces, but strictly avoid packing inside bone defects.
2. Wet Tensile Strength: The "Invisible Pillar" of Intraoperative Handling
Clinical significance: Dry-state strength does not predict wet-state performance. If a hemostat loses integrity upon contact with blood, it may fragment, migrate, or cause re-bleeding.
Material comparison:
| Material Type | Wet Tensile Strength | Key Characteristics |
|---|---|---|
| Oxidized Regenerated Cellulose (ORC) | High | Woven structure, cuttable, maintains integrity when wet |
| Plant Starch Particles (MPH) | N/A (particulate→gel) | Clot strength is 2–3 times that of physiological clot |
| Gelatin Sponge | Low–Medium | Fragile when wet |
| Collagen | Medium | Flexible but softens upon blood contact |
Selection advice:
For rough surfaces or anastomotic sites (e.g., hepatectomy, vascular anastomosis): Prioritize ORC woven type or products with high wet strength.
For endoscopic/laparoscopic procedures or deep sites: Choose particulate hemostats with long catheter applicators (e.g., 38cm or 2m tube).
3. Biocompatibility: From "Non-Harmful" to "Healing-Promoting"
Clinical significance: Postoperative inflammation, granuloma formation, adhesions, or foreign body reactions are common complications of hemostatic materials.
Key evidence from peer-reviewed research:
In a controlled minipig study (n=24), researchers evaluated ORC's biocompatibility through blood biochemistry, histopathology, and organ examination.
Blood biochemistry findings :
ALT and AST levels were elevated at 24 hours post-surgery
Both indicators returned to normal levels by 72 hours post-modeling
No significant differences in liver/kidney function, blood glucose, or inflammatory factors among groups (P > 0.05)
Histopathology findings :
At 2 weeks post-surgery: Granulation tissue formation and extensive collagen fiber deposition observed on liver wounds; wounds healed well
At 14 weeks post-surgery: Mild fibrous hyperplasia, collagen fiber deposition, and minimal inflammatory cell infiltration; complete material degradation
Hematoxylin-eosin staining of major organs (heart, liver, spleen, kidneys, lungs) showed no significant pathological changes at 14 weeks.
MPH (plant starch particles) , being 100% plant-derived and thrombin-free, has been used in over 810,000 pieces with no reported adverse events (company safety data on file).
Key comparison:
| Parameter | ORC | Starch Particles | Gelatin/Collagen |
|---|---|---|---|
| Origin | Plant-derived | Plant-derived | Animal-derived (bovine/porcine) |
| pH | Low (3.5–4.5) | Neutral | Neutral or high |
| Immunogenicity risk | Low | Extremely low | Potential |
Selection advice:
For patients with hypersensitivity or autoimmune deficiencies: Prioritize plant starch particles or high-purity ORC.
For patients requiring long-term imaging follow-up (e.g., post-cancer surgery): Both ORC and starch are radiolucent and do not interfere with CT/MRI.
4. Non-Pyrogenic Certification & Regulatory Compliance: The Safety Baseline
Clinical significance: Pyrogenic reactions (fever, chills, hypotension) are among the most dangerous acute adverse events associated with hemostats.
Mandatory certifications to verify:
| Certification/Mark | Meaning | Value to Distributors |
|---|---|---|
| Non-pyrogenic | Passed endotoxin testing | Direct patient safety guarantee |
| CE (MDR) | EU Medical Device Regulation compliance | Enables European sales |
| ISO 13485 | Quality management system | Ensures batch-to-batch consistency |
| MDSAP | Multi-country acceptance (USA, Canada, Brazil, etc.) | Facilitates global distribution |
The peer-reviewed study confirmed that the evaluated ORC material demonstrated good biocompatibility, non-pyrogenic properties, and no significant pathological changes in major organs .
Selection advice:
Distributors should only select hemostats explicitly labeled "non-pyrogenic" with supporting test reports.
For export-oriented distributors, prioritize brands that hold CE + MDSAP + ISO13485 certifications.
5. Comprehensive Material Comparison Table (Quick Decision Tool for Distributors)
| Parameter | Oxidized Regenerated Cellulose (ORC) | Plant Starch Particles (MPH) | Gelatin Sponge | Collagen |
|---|---|---|---|---|
| Time to hemostasis | ≤3 minutes | ≤1–3 minutes | 2–5 minutes | 2–4 minutes |
| Wet tensile strength | High | N/A (particle→gel) | Low | Medium |
| Absorption time | 28 days | 14 days | 4–8 weeks | 3–8 weeks |
| Complete degradation | By 56 days | By 14 days | 4–8 weeks | 3–8 weeks |
| Major organ pathology at 14 weeks | None observed | None observed | Brand-dependent | Brand-dependent |
| Non-pyrogenic | Yes | Yes | Brand-dependent | Brand-dependent |
| Animal-origin risk | No | No | Yes | Yes |
| Typical price tier | Mid–High | Mid | Low–Mid | High |
6. How to Match Product Lines to Downstream Clinic Clients
A. High Cost-Performance Line (for ambulatory clinics, community surgery, emergency wound care)
Recommended materials: Small-size ORC sheets (e.g., 2×3cm, 5×5cm) + MPH 0.5g/1g small vials
Clinical scenarios: Skin biopsy, superficial wounds, post-extraction dental bleeding, nasal hemostasis
Data support: Peer-reviewed research confirms ORC achieves complete hemostasis within 3 minutes and shows no significant pathological changes in major organs at 14 weeks post-surgery
B. Premium Line (for aesthetic clinics, tertiary hospital VIP units, international hospitals, advanced endoscopy centers)
Recommended materials: MPH 2g/3g/5g + long catheter applicators (38cm or 2m) + large-size ORC sheets (10×20cm, 30×50cm)
Clinical scenarios: Laparoscopic hepatectomy, bariatric surgery (sleeve gastrectomy), spinal surgery, thoracoscopic procedures
Evidence-based selling points:
ORC demonstrates effective prevention of liver wound hemorrhage in large-animal models
Complete material degradation confirmed by ultrasound examination over 56 days
Clot strength 2–3× higher than physiological clot
Value proposition:
"A modest increase in hemostat cost per case can potentially prevent one re-operation for postoperative hematoma, saving thousands in healthcare resources."
Conclusion & Immediate Action Steps
By 2026, wound hemostasis product selection has evolved from "does it work?" to "how fast, how safe, how convenient, how compatible?" Based on peer-reviewed evidence from the Chinese Journal of Tissue Engineering Research , distributors must verify:
Absorption rate (≤3 minutes is the benchmark)
Wet-state performance (ORC woven type > gelatin)
Biocompatibility data (72-hour return to normal ALT/AST levels; 14-week major organ pathology clear)
Non-pyrogenic + full international certifications (CE + ISO13485 + MDSAP)
Recommended dual-line product matrix for distributors:
| Product Line | Target Products | Target Clients | Key Selling Point |
|---|---|---|---|
| Volume line | Small-size ORC + MPH 0.5g/1g | High-frequency clinic use | 3-minute hemostasis, cost-per-site economics |
| Profit line | Endoscopic MPH kits + large-size ORC | High-value surgical specialties | Complete degradation, no major organ pathology |
To obtain full-text clinical studies (including the minipig liver model, DOI: 10.12307/2024.370 ), the 810,000-piece safety summary, or registration dossiers, contact the manufacturer directly.
About Surgiclean®
Hangzhou Singclean Medical Products Co., Ltd. offers MPH Absorbable Hemostatic Particles and Oxidized Regenerated Cellulose Absorbable Hemostatic Gauze, both certified to CE, NMPA, ISO13485, and MDSAP. These products are used worldwide in cardiovascular, hepatobiliary, orthopedic, endoscopic, and general surgeries for effective wound hemostasis and reliable hemostatic effect.
References:
Huo Yun, Sun Xiaoqing. Hemostatic effect of oxidized regenerated cellulose hemostatic material on minipig liver hemorrhage models. Chinese Journal of Tissue Engineering Research. 2024;28(10):1490-1496. https://en.cjter.com/2024-Vol-28-Issue-10-1490-1496.html
Huo Yun, Sun Xiaoqing. 氧化再生纤维素止血材料在猪肝脏出血创面模型中的止血效果 [Hemostatic effect of oxidized regenerated cellulose hemostatic material on minipig liver hemorrhage models]. Chinese Journal of Tissue Engineering Research. 2024;28(10):1490-1496. doi:10.12307/2024.370